Key statistics
On Tuesday, Cue Biopharma Inc (1UC:BER) closed at 0.572, 71.26% above the 52 week low of 0.334 set on Sep 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.579 |
---|---|
High | 0.586 |
Low | 0.57 |
Bid | -- |
Offer | -- |
Previous close | 0.586 |
Average volume | 381.90 |
---|---|
Shares outstanding | 75.35m |
Free float | 61.48m |
P/E (TTM) | -- |
Market cap | 50.67m USD |
EPS (TTM) | -0.6644 USD |
Data delayed at least 15 minutes, as of Jul 01 2025 20:52 BST.
More ▼
Announcements
- Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
- Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
- Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Cue Biopharma Announces Strategic Organizational Transition
- Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
- Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
- Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
- Cue Biopharma Announces Pricing of $12.0 Million Public Offering
- Cue Biopharma Announces Proposed Public Offering
More ▼